socalTECH
JANUARY 3, 2019
As we close out our contributions for the end of 2018, here's Jeb Spencer of TVC Capital. Two big lessons in 2018. Technology investing is the best job in the world, but it can be fraught with failure. What I realized in 2018 was that these people use kindness, empathy, logic and reason to achieve the outcomes they desire.
socalTECH
DECEMBER 27, 2018
Editor's note: All this week, and into the start of next year, we'll be featuring reflections on 2018 from notable investors, entrepreneurs, and others from Southern California's technology community. What was the biggest news for your company in 2018? We've always known how important it is as VCs to invest in founders.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TechCrunch LA
APRIL 22, 2019
The Los Angeles-based company’s public offering should be a nice windfall for the Chicago-based investors DNS Capital, an investment firm managing the private wealth of the Pritzker family, and Cleveland Avenue, founded by former McDonald’s executive Don Thompson; as well as the venture capital firms Kleiner Perkins and Obvious Ventures.
Tech.Co
FEBRUARY 28, 2018
By focusing on culture and peace initiatives, he’s been able to secure a number of investments between the two countries, setting a prosperous foundation of peace for the future. When your résumé includes Google, the World Economic Forum, and a TED talk, speaking at SXSW 2018 is a walk in the park.
Tech.Co
JANUARY 9, 2018
In a study by the US Department of Commerce , women in STEM jobs earn 33 percent more money than women in non-STEM positions. It is here that Arlington Economic Development (AED) has joined with CES 2018 and will host the Startup Arlington Lounge (booth #50463) at Eureka Park to showcase some of their top startups. Albrechtsen said.
TechCrunch LA
APRIL 21, 2020
It was an important launch for GM and its Chairman and CEO Mary Barra, who used a study commissioned in the wake of the ignition switch engineering scandal to accelerate her plans to transform the culture and operations at the automaker.
Xconomy
DECEMBER 7, 2017
Proceeds will be used to advance Metacrine’s lead drug candidate, MET409, into first-in-human studies during the first half of 2018. Initial studies should be completed by the end of the year, the San Diego-based company said.
Expert insights. Personalized for you.
113 
Let's personalize your content